Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders

NCT ID: NCT02627014

Last Updated: 2017-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine whether treatment of temporomandibular joint is more effective than usual care in patients with chronic migraine and temporomandibular disorders to reduce pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Migraine Temporomandibular Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

INTERVENTION

Manual Therapy in temporomandibular joint and cervical region. Home physical therapy in temporomandibular joint and cervical region.

Group Type EXPERIMENTAL

Manual therapy

Intervention Type OTHER

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Home physical therapy

Intervention Type OTHER

once a day: 15 minutes

CONTROL

Manual therapy in cervical region Home physical therapy in cervical region

Group Type ACTIVE_COMPARATOR

Manual therapy in cervical region

Intervention Type OTHER

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Home physical therapy in cervical region

Intervention Type OTHER

once a day: 15 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Manual therapy

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Intervention Type OTHER

Home physical therapy

once a day: 15 minutes

Intervention Type OTHER

Manual therapy in cervical region

6 treatments: 2 treatments for week

1 treatment = 30 minutes

Intervention Type OTHER

Home physical therapy in cervical region

once a day: 15 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic migraine (ICHD\_III beta, 2013)
* Temporomandibular disorders (RDC/TMD)

Exclusion Criteria

* other neurological disease
* psychiatric diseases
* Physical therapy treatment in the last 6 months
* dental treatment in the last 6 months
* surgery or trauma in the orofacial region
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Miguel Servet

OTHER

Sponsor Role collaborator

Cardenal Herrera University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eva Segura Ortí

Eva Segura Ortí (PhD)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Miriam Garrigós

Role: PRINCIPAL_INVESTIGATOR

Universidad San Jorge

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad San Jorge

Zaragoza, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CM_TMD_1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.